Vectus Biosystems Limited
ASX:VBS.AX
0.08 (AUD) • At close September 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| -2.13 | -3.449 | -3.994 | -3.861 | -2.996 | -1.596 | -2.587 | -3.794 | -3.211 | -1.656 | -1.482 | -1.238 |
Depreciation & Amortization
| 0.059 | 0.047 | 0.02 | 0.017 | 0.02 | 0.023 | 0.02 | 0.028 | 0.057 | 0.145 | 0.056 | 0.065 |
Deferred Income Tax
| 0 | 0.008 | -0.25 | -0.496 | -0.604 | -0.533 | -1.18 | 0.117 | -3.154 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0.002 | 0.009 | 0.19 | 0.032 | 0.123 | 0.214 | 0.162 | 0.194 | 0 | 0 | 0 |
Change In Working Capital
| 0.24 | 0.815 | -0.971 | -0.66 | -0.619 | 0.41 | 0.966 | -0.279 | 0.35 | -0.009 | 0 | 0 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -0.058 | 0.105 | -0.201 | -0.271 | -0.533 | 0.135 | 0.903 | -0.217 | 0.174 | 0 | 0 | 0 |
Other Working Capital
| 0.299 | 0.71 | -0.77 | -0.389 | -0.087 | 0.275 | 0.063 | -0.062 | 0.176 | -0.009 | 0 | 0 |
Other Non Cash Items
| -0.02 | 0.224 | 0.745 | 1.554 | 1.166 | 0.533 | 1.18 | -0.01 | 0.135 | -0.121 | 0.133 | 0.051 |
Operating Cash Flow
| -2.026 | -2.353 | -4.441 | -3.256 | -3.002 | -1.041 | -1.387 | -3.893 | -2.611 | -1.641 | -1.293 | -1.122 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -0.075 | -0.017 | -0.021 | 0 | 0 | 0 | 0 | -0.039 | -0.082 | -0.009 | -0.035 | -0.007 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.034 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.034 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -0.034 | 0 | 0 |
Investing Cash Flow
| -0.075 | -0.017 | -0.021 | 0 | 0 | 0 | 0 | 3.995 | -4.116 | -0.043 | -0.035 | -0.007 |
Financing Activities: | ||||||||||||
Debt Repayment
| 0 | -0.442 | -0.035 | -0.515 | -5.65 | -0.754 | -0.72 | -0.005 | -0.021 | -0.021 | -0.019 | -0.673 |
Common Stock Issued
| 0 | 4.538 | 0 | 6.887 | 0 | 0 | 0 | 0 | 5.173 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | -0.063 | 0 | -0.113 | 0 | 0 | 0 | 0 | -0.409 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.567 | 0 | 0 | 0 |
Other Financing Activities
| 0 | 4.039 | -0.035 | 6.348 | 11.294 | 1.796 | 1.632 | -0.005 | 4.588 | 3.779 | 0.562 | 2.718 |
Financing Cash Flow
| -0.041 | 4.039 | -0.035 | 6.348 | 5.644 | 1.042 | 0.912 | -0.005 | 4.743 | 3.759 | 0.542 | 2.044 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0.175 | 0 | 0.001 | 0.341 |
Net Change In Cash
| -2.142 | 1.67 | -4.497 | 3.093 | 2.642 | 0.001 | -0.475 | 0.096 | -2.159 | 2.074 | -0.786 | 1.257 |
Cash At End Of Period
| 0.809 | 2.951 | 1.281 | 5.778 | 2.685 | 0.043 | 0.042 | 0.517 | 0.421 | 2.546 | 0.472 | 1.258 |